US-based biotechnology company Acorda Therapeutics, has entered into a settlement with Aurobindo Pharma to resolve pending patent litigation on Ampyra (dalfampridine) extended release tabl…
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
